| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
|
Clin Cancer Res
|
2006
|
1.93
|
|
2
|
Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis.
|
Breast Cancer Res Treat
|
2005
|
1.52
|
|
3
|
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ.
|
Breast Cancer Res
|
2007
|
1.35
|
|
4
|
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
|
Carcinogenesis
|
2009
|
1.27
|
|
5
|
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines.
|
Breast Cancer Res Treat
|
2009
|
1.25
|
|
6
|
Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).
|
J Mol Med (Berl)
|
2006
|
1.24
|
|
7
|
Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis.
|
J Cancer Res Clin Oncol
|
2003
|
1.20
|
|
8
|
Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism.
|
Int J Cancer
|
2012
|
1.18
|
|
9
|
Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up.
|
Clin Cancer Res
|
2003
|
1.14
|
|
10
|
Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer.
|
Clin Cancer Res
|
2004
|
1.13
|
|
11
|
Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice.
|
Am J Pathol
|
2009
|
1.04
|
|
12
|
On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer.
|
Breast Cancer Res Treat
|
2007
|
1.02
|
|
13
|
Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation.
|
Pharmacogenet Genomics
|
2005
|
1.02
|
|
14
|
Characterization of endometrial mesenchymal stem-like cells obtained by endometrial biopsy during routine diagnostics.
|
Fertil Steril
|
2011
|
0.99
|
|
15
|
Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation.
|
FEBS J
|
2013
|
0.98
|
|
16
|
Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity.
|
J Immunol
|
2009
|
0.98
|
|
17
|
Male smokers have a decreased success rate for in vitro fertilization and intracytoplasmic sperm injection.
|
Fertil Steril
|
2003
|
0.96
|
|
18
|
Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast.
|
Oncol Rep
|
2004
|
0.92
|
|
19
|
Metformin alters insulin signaling and viability of human granulosa cells.
|
Fertil Steril
|
2005
|
0.91
|
|
20
|
Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (beta4GalT-7) deficient form of Ehlers-Danlos syndrome.
|
Hum Mol Genet
|
2007
|
0.91
|
|
21
|
The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1.
|
Int J Cancer
|
2011
|
0.91
|
|
22
|
MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors.
|
Fertil Steril
|
2013
|
0.91
|
|
23
|
Advanced follicle development in xenografted prepubertal ovarian tissue: the common marmoset as a nonhuman primate model for ovarian tissue transplantation.
|
Fertil Steril
|
2010
|
0.90
|
|
24
|
Endocytosis of the dermatan sulfate proteoglycan decorin utilizes multiple pathways and is modulated by epidermal growth factor receptor signaling.
|
Biochimie
|
2007
|
0.89
|
|
25
|
Aberrant expression of the pluripotency marker SOX-2 in endometriosis.
|
Fertil Steril
|
2010
|
0.89
|
|
26
|
Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma.
|
Genes Chromosomes Cancer
|
2006
|
0.89
|
|
27
|
Breast cancer molecular subtypes--modern therapeutic concepts for targeted therapy of a heterogeneous entity.
|
Maturitas
|
2012
|
0.88
|
|
28
|
Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy.
|
BMC Cancer
|
2008
|
0.87
|
|
29
|
Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.
|
Gynakol Geburtshilfliche Rundsch
|
2008
|
0.86
|
|
30
|
COX-2 overexpression in peritoneal lesions is correlated with nonmenstrual chronic pelvic pain.
|
Eur J Obstet Gynecol Reprod Biol
|
2005
|
0.86
|
|
31
|
Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life.
|
Inflamm Bowel Dis
|
2007
|
0.86
|
|
32
|
Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis.
|
J Biol Chem
|
2005
|
0.85
|
|
33
|
Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer.
|
Anticancer Res
|
2006
|
0.83
|
|
34
|
Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells.
|
Int J Cancer
|
2010
|
0.82
|
|
35
|
Overexpression of Endothelin-A-receptor in breast cancer: regulation by estradiol and cobalt-chloride induced hypoxia.
|
Int J Oncol
|
2005
|
0.82
|
|
36
|
Endothelin-1, Endothelin-A- and Endothelin-B-receptor expression in preinvasive and invasive breast disease.
|
Oncol Rep
|
2004
|
0.82
|
|
37
|
Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.
|
Anticancer Res
|
2009
|
0.82
|
|
38
|
Caveolin-1 expression in benign and malignant lesions of the breast.
|
World J Surg Oncol
|
2007
|
0.81
|
|
39
|
Current Issues of Targeted Therapy in Metastatic Triple-Negative Breast Cancer.
|
Breast Care (Basel)
|
2011
|
0.81
|
|
40
|
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.
|
Breast Cancer Res Treat
|
2009
|
0.81
|
|
41
|
Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes.
|
Eur J Cancer
|
2011
|
0.81
|
|
42
|
Physiological concept for a blood based CFTR test.
|
Cell Physiol Biochem
|
2006
|
0.80
|
|
43
|
The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling.
|
Gynecol Endocrinol
|
2014
|
0.79
|
|
44
|
Targeting of syndecan-1 by micro-ribonucleic acid miR-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and interleukin-6 secretion.
|
Fertil Steril
|
2012
|
0.79
|
|
45
|
[Long-cycle treatment in oral contraception].
|
Ther Umsch
|
2009
|
0.79
|
|
46
|
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling.
|
Mol Cancer
|
2014
|
0.79
|
|
47
|
Serum estradiol and progesterone in the mid-luteal phase predict clinical pregnancy outcome in IVF/ICSI cycles.
|
Gynecol Endocrinol
|
2013
|
0.78
|
|
48
|
Evaluation of placental syndecan-1 expression in early pregnancy as a predictive fetal factor for pregnancy outcome.
|
Prenat Diagn
|
2012
|
0.78
|
|
49
|
FSH prevents depletion of the resting follicle pool by promoting follicular number and morphology in fresh and cryopreserved primate ovarian tissues following xenografting.
|
Reprod Biol Endocrinol
|
2012
|
0.78
|
|
50
|
Role of syndecan-3 polymorphisms in obesity and female hyperandrogenism.
|
J Mol Med (Berl)
|
2009
|
0.77
|
|
51
|
Endometriosis: a genetic disease.
|
Drugs Today (Barc)
|
2003
|
0.77
|
|
52
|
[Contraception in women with special problems].
|
Ther Umsch
|
2009
|
0.77
|
|
53
|
Menstrual abnormalities and predisposition to pregnancy-related hypertensive disorders: a retrospective study.
|
Gynecol Endocrinol
|
2010
|
0.77
|
|
54
|
[Does hormonal contraception increase the risk for tumors?].
|
Ther Umsch
|
2009
|
0.77
|
|
55
|
HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression.
|
Int J Cancer
|
2014
|
0.76
|
|
56
|
Perioperative complications in conventional and microsurgical abdominal myomectomy.
|
Arch Gynecol Obstet
|
2010
|
0.76
|
|
57
|
Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART.
|
J Assist Reprod Genet
|
2005
|
0.76
|
|
58
|
Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation.
|
J Assist Reprod Genet
|
2004
|
0.75
|
|
59
|
Effects of black cohosh on estrogen biosynthesis in normal breast tissue in vitro.
|
Maturitas
|
2007
|
0.75
|
|
60
|
Imaging of fetal thymus in pregnant women with rheumatic diseases.
|
J Perinat Med
|
2014
|
0.75
|
|
61
|
Assessment of three-dimensional sonographic features of polycystic ovaries after laparoscopic ovarian electrocautery.
|
Fertil Steril
|
2007
|
0.75
|
|
62
|
Impact of testosterone on the expression of organic anion transporting polypeptides (OATP-1A2, OATP-2B1, OATP-3A1) in malignant and non-malignant human breast cells in vitro.
|
Maturitas
|
2012
|
0.75
|
|
63
|
Spontaneous conception and live birth after gonadotoxic chemotherapy for an aggressive bilateral ovarian Burkitt's lymphoma.
|
Eur J Obstet Gynecol Reprod Biol
|
2011
|
0.75
|
|
64
|
Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
|
Breast Cancer Res Treat
|
2007
|
0.75
|
|
65
|
[Oral contraception - doses and way of administration].
|
Ther Umsch
|
2009
|
0.75
|
|
66
|
Endobronchial mucosal metastases in breast cancer: a rare metastatic pattern.
|
Lancet Oncol
|
2002
|
0.75
|
|
67
|
[Contraception in adolescence and perimenopause].
|
Ther Umsch
|
2009
|
0.75
|
|
68
|
The impact of testosterone, tibolone and black cohosh on purified mammary and placental 17β-hydroxysteroid dehydrogenase type 1.
|
J Enzyme Inhib Med Chem
|
2014
|
0.75
|
|
69
|
Effects of hormone therapy on estrogen synthesis from E1S in the mammary gland of postmenopausal women.
|
Maturitas
|
2008
|
0.75
|
|
70
|
Effect of testosterone on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
|
J Steroid Biochem Mol Biol
|
2009
|
0.75
|
|
71
|
Detection of nonpigmented endometriotic lesions with 5-aminolevulinic acid-induced fluorescence.
|
J Am Assoc Gynecol Laparosc
|
2004
|
0.75
|
|
72
|
Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy.
|
Am J Obstet Gynecol
|
2006
|
0.75
|
|
73
|
Fetal myocardial peak systolic strain before and after intrauterine red blood cell transfusion--a tissue Doppler imaging study.
|
J Perinat Med
|
2012
|
0.75
|